November 21, 2024
Chunlan Dong, Ying Wang, Kefeng Gong, Teng Lu, Frank Xing, and Qian Shi
IDO1 is a major mechanism of immunosuppression in tumors, with expression of IDO1 by tumor cells resulting in aggressive tumor growth and disease resistance to T cell-targeting immunotherapies.
To investigate the de-suppression of T cell function through inhibition of the IDO1-mediated tryptophan metabolism pathway, CrownBio has established an in vitro assay system which allows the robust LC-MS/MS detection of the levels of N-formyl-kynurenine (a tryptophan metabolism product) in culture medium, plasma, and tumor tissue.
This poster details initial investigations into IDO1 expression with and without IFN-γ induction, how IDO1 inhibition reduces the levels of kynurenine in culture medium, and the correlation of the reduction of kynurenine production with the re-activation of T cell activity.
Your privacy is important to us.
We'll never share your information.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2023-05-22
2021-10-28
landing_page
PDX/Databases